News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Investor
QuintilesIMS (Q) Announces Pricing Of Senior Notes 2/24/2017
4 Large Cap Biotechs To Stock Up On 2/24/2017
Fitbit (FIT): Turnaround Story Or Falling Knife? 2/24/2017
Karolinska Development AB Notes Oncopeptides' Successful Listing On Nasdaq Stockholm - Company's Earn-Out Has A Current Market Value Of SEK 26.7 Million 2/24/2017
InstantLabs Secures Controlling Investment From Angeon Group 2/24/2017
Provectus Provides Information On Rights Offering Deadline 2/24/2017
2 Biotechs That Had a Rough 2016 But May Be Poised for a Turnaround This Year 2/23/2017
Why This 11-Employee Massachusetts Biotech's Market Cap Doubled Yesterday 2/23/2017
3 Overlooked Biotechs That Deserve More Attention 2/23/2017
Serial Investor Carl Icahn Takes Stake in Bristol-Myers Squibb (BMY), Stock Jumps 2/23/2017
Carl Icahn Can't Make Bristol-Myers Squibb (BMY) Buyable 2/23/2017
With New Cash and Cancer Targets, Analyst Sees Almost 200% Upside In Sierra Oncology 2/23/2017
3 Things Gilead (GILD)' CEO Just Said That You'll Want to Know 2/23/2017
RedHill Biopharma (RDHL) Announces Availability Of Its Annual Report On Form 20-F Through Its Website 2/23/2017
Price Increase For Evonik Industries’s CYROLITE Multipolymers 2/23/2017
MMJ PhytoTech Announces Harvest One Closes C$25 Million Placement 2/23/2017
A Letter From The ChromaDex, Inc. Chief Executive Officer 2/23/2017
Innophos Holdings, Inc. Declares Quarterly Dividend 2/23/2017
PAVmed (PAVM) Announces Exchange Offer 2/23/2017
Cannabics Pharma Provides Shareholders Update Regarding Increased Volume In Its Shares 2/23/2017
Global Small Caps Initiates Coverage On Nutra Pharma Corp. (NPHC) 2/23/2017
This Tiny Biotech Grew 412% in 2016. A Look at Whether It Can Continue in 2017 2/22/2017
This Marijuana Stock Is Already Worth $3 Billion—Is It a Buy? 2/22/2017
QuintilesIMS (Q) Announces Offering Of Senior Notes And Proposed Refinancing Of Existing Indebtedness 2/22/2017
venBio Sends Letter To Immunomedics (IMMU) Stockholders 2/22/2017
PTC Therapeutics (PTCT) Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 2/22/2017
Acasti Pharma Announces Closings Of Concurrent Public Offering Of Units And Private Placement Of Convertible Debentures And Warrants 2/22/2017
Arch Therapeutics $6.1 Million Registered Direct Offering 2/22/2017
Luminex (LMNX) Announces Initiation Of Cash Dividend 2/22/2017
Landauer (LDR) Declares Regular Cash Dividend 2/22/2017
Apollo Therapeutics Funding Of Four Initial Projects And Operational Update 2/22/2017
Notice Of Annual General Meeting In Getinge 2/22/2017
Global Blood Therapeutics (GBT) Prices A $125.0 Million Upsized Common Stock Public Offering 2/22/2017
Global Blood Therapeutics (GBT) Announces Proposed Public Offering Of Common Stock 2/22/2017
Microbot Medical Inc. To Ring The Nasdaq Stock Market Closing Bell 2/22/2017
BioCrossroads Release: Indiana's Life Sciences Industry Economic Impact Climbs To $63 Billion 2/22/2017
Pfizer (PFE) Abandons European Listings Due To Liquidity Issues 2/22/2017
4 Biopharma Stocks a Billionaire Investor Just Bought 2/22/2017
Rumored Acquisition Target Bristol-Myers Squibb (BMY) Names 3 New Directors, Plans $2 Billion Accelerated Share Buyback 2/21/2017
The 10 Biggest Losers in Biopharma Last Year 2/21/2017
Here’s Where Jobs in Shrinking Life Sciences Marketing Departments Are Headed 2/21/2017
How Much Money Embattled Theranos Has Left in the Bank 2/21/2017
Antibe Therapeutics (ATE.V) Engages MKR Group For U.S. Investor Relations 2/21/2017
3 Stocks To Invest In Big Pharma 2/21/2017
3 Top Drug Stocks That Can Be Purchased On The Cheap This Winter 2/21/2017
Abbott (ABT) Commences Exchange Offers And Consent Solicitations For St. Jude Medical (STJ) Notes 2/21/2017
EnteroMedics (ETRM) Regains Compliance With Nasdaq Listing Requirement 2/21/2017
MYnd Analytics Invited to Present at the At the NASDAQ Market Site 2/21/2017
Approval For Listing Of Shares Of Solasia Pharma K.K. On The Tokyo Stock Exchange Mothers 2/21/2017
Generex Biotechnology Corporation (GNBT) Provides Access Information For Investor Conference Call Scheduled For February 22, 2017 2/21/2017
BioTalent Canada Release: New Report: Newcomers To Canada Need Ways To Show Skills To Biotech Employers 2/21/2017
Abzena Release: Trading And Business Update 2/21/2017
International Isotopes (INIS) Announces The Successful Private Placement Of Its Preferred Series C Stock 2/21/2017
Why Biotech Looks Like A Good Bet In 2017 2/21/2017
Kendall Life Sciences Announces Official Launch Of Industry-Specific Internet Strategy Service Offering Including Website Development And Design Due To Client Demand 2/21/2017
Invacare (IVC) Declares Quarterly Dividend 2/21/2017
Orexo (ORXOF) Completes Bond Buyback Program 2/20/2017
Aldeyra (ALDX) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/20/2017
Alexion (ALXN) Who? Buy These 4 Biotech Stocks Instead 2/20/2017
Zenosense (ZENO): Is Something Big On The Cards? 2/20/2017
Minnesota's Skyline Medical Compliant With All Nasdaq Listing Criteria Once Again 2/20/2017
Why Biocryst (BCRX) Is A High-Risk High-Reward Stock 2/20/2017
Why Edwards Lifesciences (EW) Could Bounce Back 2/17/2017
Biostage Announces Closing Of $8.0 Million Public Offering 2/17/2017
XTL Biopharma (XTLB) Announces $2.5 Million Registered Direct Offering 2/17/2017
CEL-SCI (CVM) Announces $1.0 Million Registered Direct Offering 2/17/2017
AbbVie (ABBV) Announces $5 Billion Increase To Stock Repurchase Program 2/17/2017
2 Biotechs That Might Help With Investor Depression 2/17/2017
A Look at Whether AbbVie (ABBV) Could Eventually Face the Same Issues as Gilead (GILD) 2/17/2017
How Bristol-Myers Squibb (BMY) And Pfizer (PFE) Are Stomping On Their Blood Thinner Rivals 2/17/2017
Why Investors Are Betting Big Against Gilead (GILD)'s Possible Acquisition Candidate Intercept Pharma (ICPT) 2/17/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug 2/17/2017
3 Biotech Stocks To Put In Your Investment Portfolio This Month 2/17/2017
HEALTHSOUTH Declares Dividend On Common Stock 2/17/2017
BioTime (BTX) Announces Closing Of Public Offering Of Common Stock 2/16/2017
Johnson & Johnson (JNJ) Publishes Prospectus For Actelion (ALIOF.PK) Tender Offer 2/16/2017
Windtree Therapeutics (WINT) Completes $10.5 Million Private Offering 2/16/2017
5 Ways Booming Allergan (AGN) Can Keep Up Momentum 2/16/2017
Teva (TEVA) Files 2016 Annual Report On Form 20-F 2/16/2017
Teva (TEVA) Has Really Bottomed Out This Time 2/16/2017
Acura Pharma (ACUR) Common Stock To Trade On The OTCQB Market 2/16/2017
3 Biotech Stocks Rookie Investors Should Check Out 2/16/2017
Merck & Co. (MRK)’s Fight Against Infectious Disease Goes Digital With Launch Of ILÚM Health Solutions 2/16/2017
GluSense Ltd. Receives Investment From JDRF T1D Fund 2/16/2017
Amedica Granted 180-Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule 2/15/2017
Aldeyra (ALDX) Prices Public Offering Of Common Stock 2/15/2017
Luxcel Biosciences , Axiogenesis And BMG LABTECH GmbH Secure €2.5m European Investment To Develop And Launch Cell Metabolism Analysis Platform: "Metacell-TM" 2/15/2017
MYOS RENS Technology Adopts Shareholder Rights Plan 2/15/2017
Why $3.75 Billion Is The Magic Number For Valeant (VRX) 2/15/2017
2 Biotechs Taking on the $20 Billion Alzheimer's Market Full Force 2/15/2017
Is There A Silver Lining For Fitbit (FIT)? 2/15/2017
Zoetis (ZTS) Declares Second Quarter 2017 Dividend 2/15/2017
Waters Corporation (WAT) Announces 2017 Investor Day And Webcast 2/15/2017
Biotech IPOs Slow As Trump-Sown Uncertainty Rattles Nerves On Wall Street 2/15/2017
Immuron Significantly Rerated By European/US Analyst's Report 2/15/2017
Auris Med (EARS) Announces Proposed Public Offering Of Common Shares And Warrants 2/15/2017
Generex Biotechnology Corporation (GNBT) Announces Elimination Of Outstanding Derivative Securities 2/15/2017
Auris Med (EARS) Announces Pricing Of $10 Million Public Offering 2/15/2017
Why 2017 Could be a Transition Year for Booming Seattle Genetics (SGEN) 2/14/2017
Life Spine Achieved 38% Revenue Growth Over Previous Year And Launched 27 Products In 2016 Including The Broadest Expandable Offering In Market 2/14/2017
Reminder: Ligand (LGND) To Host Analyst Day On February 28th In New York City 2/14/2017
Misonix (MSON) Reports Receipt of Deficiency Letter From The Nasdaq Stock Market LLC 2/14/2017
Marken (Formerly known as Marken Time Critical) Shares Recent Client Survey Results 2/14/2017
IRadimed Corporation Poised For Market Domination 2/14/2017
Marina Biotech (MRNA) Completes Share Issuance At A Valuation Of $0.29 Per Share 2/14/2017
Prima Biomed (PRR.AX) Receives ~A$860,000 Tax Credit Payment From French Government 2/14/2017
Aldeyra (ALDX) Proposes Public Offering Of Common Stock 2/14/2017
Tetra Discusses Clinical Program In New Interview With CFN Media 2/14/2017
Ex-Pharmacyclics (PCYC) CEO, COO Take 17% Stake in Bay Area's Pulse Biosciences 2/13/2017
Why Immunomedics (IMMU)' $2 Billion Deal With Seattle Genetics (SGEN) Has venBio Ticked Off and Red-Faced 2/13/2017
Array BioPharma (ARRY) Has a Potential Blockbuster Melanoma Drug On Its Hands 2/13/2017
This Breakthrough In Biotech Has Enormous Investment Potential 2/13/2017
Why Intercept Pharma (ICPT) Stock Jumped Nearly 10% On Friday After Providing Phase III Update 2/13/2017
Provectus Announces Extension Of Rights Offering 2/13/2017
venBio Comments On Immunomedics (IMMU) Partnership Announcement 2/13/2017
Alnylam (ALNY) Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 2/13/2017
Becton, Dickinson and Company (BDX) Release: Perhaps The Big Biotech Needs To Develop An Antidepressant--Just To Give To Its Shareholders. 2/13/2017
Kitov (KTOV) Announces Settlement Agreement With Minority Shareholder Of Recently Acquired Tyrnovo 2/13/2017
Novasep Invests In A €27m Viral Vector Production Facility 2/13/2017
Innovation Legislation Seeks Boost In Illinois’ Bio-based Economy 2/13/2017
3 Top Biotech Stocks to Buy on Sale 2/13/2017
NanoViricides, Inc. (NNVC.PK) Reports The Company's Director Dr. Boniuk Converted Series B Debenture To Equity Effectively Raising $5 Million In New Equity For The Company 2/13/2017
Helsinn Launches "Helsinn Cares" Patient Support Services In The U.S. 2/13/2017
3 Biotech Stocks Able to Weather an Unstable Trump Administration 2/10/2017
Novo A/S Becomes New Long-Term Strategic Shareholder In Evotec AG (EVTG.F) 2/10/2017
BioTime (BTX) Announces Proposed Public Offering Of Common Stock 2/10/2017
BioTime (BTX) Announces Pricing Of Public Offering Of Common Stock 2/10/2017
Pulse Biosciences Announces Healthcare Executives And Entrepreneurs Robert Duggan And Dr. Maky Zanganeh Have Acquired A Combined Interest Of 17.1% Of The Company 2/10/2017
Moleculin Biotech (MBRX) Announces Pricing Of $5 Million Underwritten Public Offering 2/10/2017
Biostage Announces $8.0 Million Public Offering 2/10/2017
Key Takeaways From Valeant (VRX)'s Fall From Grace 2/10/2017
Pharma Bro Martin Shkreli Heads Up Software Startup And Wants Your Investment 2/10/2017
GW Pharma (GWPH) Is Set To Benefit As Cannabis Takes On Cancer 2/10/2017
Dow Chemical  (DOW)’s Silicone Business Play: What It Means for Medtech 2/10/2017
Immunomedics (IMMU) Announces Postponement Of 2016 Annual Meeting 2/10/2017
How Gilead (GILD) Just Lost $9 Billion in Market Value This Week 2/10/2017
A Look at Whether It's Too Late to Jump on These 3 Sizzling Biotechs' Train 2/9/2017
Applied BioCode, Inc. Listed On Taiwan Emerging Market Stock Exchange 2/9/2017
Quad-C Management Announces Investment In Pharm-Olam International Ltd. 2/9/2017
Helius Medical Technologies Announces Proposed Public Offering Of Class A Common Stock 2/9/2017
Hill-Rom Announces Launch Of $300 Million Private Placement 2/9/2017
Apricus Biosciences (APRI) Receives Positive Nasdaq Listing Determination 2/9/2017
AmerisourceBergen (ABC) Declares Quarterly Dividend 2/9/2017
Zynerba (ZYNE) Announces Full Exercise Of Underwriters' Option To Purchase Additional Shares 2/9/2017
Helius Medical Technologies Announces CAD$10.8 Million Public Offering Of Class A Common Stock 2/9/2017
Biocept, Inc. (BIOC)'s CEO Issues Letter To Stockholders 2/9/2017
Sierra Oncology Announces Pricing Of Public Offering Of Common Stock 2/9/2017
angelMD Invests In Brain Cancer Treatment Innovator Curtana Pharmaceuticals 2/9/2017
Bold Move: Trump's HHS Nominee Made Dozens Of Stock Trades During Investigation 2/9/2017
4 Biotech Stocks Worthy Enough to be Brokers' Favorites 2/8/2017
Amfil Technologies Inc. Reduces The Issued & Outstanding Share Count By Nearly 50% 2/8/2017
Coherus Announces Proposed Public Offering Of Common Stock 2/8/2017
Why Endologix Stock Got A 20% Boost In January 2/8/2017
Interpace Diagnostics Announces Closing Of $3.9 Million Public Offering 2/8/2017
Boston Therapeutics Business Update 2/7/2017
Karolinska Development AB — Offer On A Set-Off Share Issue To Convertible Holders To Strengthen The Company’s Equity Position 2/7/2017
Neovacs 2017 Financial Calendar 2/7/2017
Bio-Techne (TECH) Declares Dividend 2/7/2017
Why Struggling Alkermes (ALKS) Could Make a Comeback in 2017 2/7/2017
Top 4 Challenges To Biosimilar Growth 2/7/2017
Notice Of The Date Of Zealand Pharma  (ZEAL.CO)'s Annual General Meeting 2017 And Of Deadline For Proposals For The Agenda 2/7/2017
Oncobiologics (ONSIU) Announces Term Extension Of Series A Warrants 2/7/2017
2 Biotech Stocks That Could Be in Trouble if President Trump's Proposals Become Reality 2/7/2017
This Can Be Patheon (PTHN)'s Fate in Trump's Call for Increased Drug Production 2/6/2017
3 Biotechs Breathing Down Bristol-Myers Squibb (BMY)'s Neck 2/6/2017
3 Reasons TransEnterix (TRXC) Stock Could Fall 2/6/2017
Obesity Massachusetts Startup Allurion Banks $19 Million 2/6/2017
Pulmatrix (PULM) Announces Over $3.0 Million Registered Direct Offering 2/6/2017
Rigel (RIGL) Announces Closing Of Public Offering Of Common Stock And Full Exercise Of Option To Purchase Additional Shares 2/6/2017
ISS Endorses Full Slate Of venBio Nominees At Immunomedics (IMMU) 2/6/2017
PAVmed (PAVM) Announces Warrants Now Exercisable For Cash 2/6/2017
MiMedx Board Of Directors Authorizes $10 Million Increase To The Company's Share Repurchase Program 2/6/2017
BBI Group Announce £14 Million Investment To Boost Capacity And Long Term Growth 2/6/2017
Allergan (AGN) Provides Board And Annual Shareholder Meeting Updates 2/6/2017
MYOS RENS Technology Announces $2,125,000 Registered Direct Offering 2/6/2017
3rd Stemline (STML) Patient Died in Clinical Trial One Day Before $45 Million Public Offering 2/3/2017
These 2 Massachusetts Med Device Makers Just Gained $4.5 Billion in Market Cap This Week 2/3/2017
Asterias Biotherapeutics Extends The Expiration Date Of Certain Warrants And Provides Update On Cash Position 2/3/2017
Neos Therapeutics (NEOS) Announces Pricing Of Underwritten Public Offering Of $25 Million Of Common Stock 2/3/2017
Pfizer (PFE) Commences $5 Billion Accelerated Share Repurchase 2/3/2017
Dicerna (DRNA) Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 2/3/2017
OrbiMed Comments On Immunomedics (IMMU) Proxy Contest 2/3/2017
Interpace Diagnostics Announces Proposed Public Offering Of Common Stock 2/3/2017
Interpace Diagnostics Announces Pricing Of Public Offering To Raise $3.6 Million 2/3/2017
Why Merck & Co. (MRK) Can't Rest Easy On Its Throne 2/3/2017
Above The Rise Of Merck & Co. (MRK)’s Gardasil Vaccine, A Specter Is Looming 2/3/2017
Why This Big Biotech Could be Biogen (BIIB)'s Downfall 2/3/2017
Why Bay Area's Exelixis (EXEL) Surged 22% in January 2/2/2017
Ampersand Completes Growth Equity Investment In Corpus Medical 2/2/2017
Entellus Medical (ENTL) Bags $37.2 Million in Stock Sale 2/2/2017
The One Reason EXACT Sciences (EXAS) Skyrocketed 42% in January 2/2/2017
SCORR Marketing Releases Annual Report On Marketing Trends In The Health Sciences Industry 2/2/2017
Rentschler Biotechnologie GmbH & Co. And LEUKOCARE Announce Strategic Alliance And Equity Investment 2/2/2017
Are Teva (TEVA)'s Best Days Behind It? 2/2/2017
Nordic Nanovector: Share Options Granted, Including Options To Primary Insiders 2/2/2017
Nordic Nanovector: Share Capital Increase Registered 2/2/2017
3 Biotechs Under $10 Investors Should Pay Attention to in 2017 2/1/2017
Cerulean (CERU) Announces Review Of Strategic Alternatives 2/1/2017
Synergy Pharma (SGYP) Announces Pricing Of Public Offering Of Common Stock 2/1/2017
Biogen (BIIB) Completes Separation Of Global Hemophilia Business, Bioverativ (BIVVV) 2/1/2017



//-->